Description
RetoMax is a product based on retatrutide, an investigational molecule that acts simultaneously on GLP-1, GIP, and glucagon receptors. Retatrutide is being studied in clinical trials in the context of metabolic control and body-weight management.
Mechanism of action:
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. The combined activity of these pathways is being investigated for potential effects on appetite, energy metabolism, glucose regulation, and body weight.
PrimeMAX Format:
The product is presented as a sterile multi-dose pen injector with a step-by-step dosing mechanism.
Package Includes:
Automated injector, micro-needles, alcohol swabs, and an individual Dosing Card.
Storage and Transportation:
Storage and transportation conditions should comply with the manufacturer’s official instructions and the requirements applicable to the specific product.
Reviews
There are no reviews yet.